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Background: The causes of sporadic amyotrophic lateral sclerosis (SALS) and other types of motor neuron disease
(MND) remain largely unknown. Heavy metals have long been implicated in MND, and it has recently been shown
that inorganic mercury selectively enters human locus ceruleus (LC) and motor neurons. We therefore used silver
nitrate autometallography (AMG) to look for AMG-stainable heavy metals (inorganic mercury and bismuth) in LC
and motor neurons of 24 patients with MND (18 with SALS and 6 with familial MND) and in the LC of 24 controls.
Results: Heavy metals in neurons were found in significantly more MND patients than in controls when comparing:
(1) the presence of any versus no heavy metal-containing LC neurons (MND 88%, controls 42%), (2) the median
percentage of heavy metal-containing LC neurons (MND 9.5%, control 0.0%), and (3) numbers of individuals with
heavy metal-containing LC neurons in the upper half of the percentage range (MND 75%, controls 25%). In MND
patients, 67% of remaining spinal motor neurons contained heavy metals; smaller percentages were found in
hypoglossal, nucleus ambiguus and oculomotor neurons, but none in cortical motor neurons. The majority of
MND patients had heavy metals in both LC and spinal motor neurons. No glia or other neurons, including
neuromelanin-containing neurons of the substantia nigra, contained stainable heavy metals.
Conclusions: Uptake of heavy metals by LC and lower motor neurons appears to be fairly common in humans,
though heavy metal staining in the LC, most likely due to inorganic mercury, was seen significantly more often in MND
patients than in controls. The LC innervates many cell types that are affected in MND, and it is possible that MND is
triggered by toxicant-induced interactions between LC and motor neurons.
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The causes of most cases of amyotrophic lateral sclerosis
(ALS), the most common form of motor neuron disease
(MND), as well as the other subtypes of MND, are still
unknown [1]. So far only a modest proportion of spor-
adic MND patients have been found to harbour causa-
tive genetic mutations, and attention has again turned to
the possibility that in some patients the disease may be
caused by an environmental toxicant that affects motor
neurons preferentially. The recent finding that one metal
toxicant, inorganic mercury, enters the human locus cer-
uleus (LC) and motor neurons selectively after mercury
self-injection suggests this pathway could be used by
toxicants to enter and damage motor neurons [2].* Correspondence: roger.pamphlett@sydney.edu.au
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article, unless otherwise stated.The LC has many interactions with motor neurons so
it is possible that some combination of toxicant uptake
by the LC and motor neurons might underlie MND. A
previous study of ours using the histochemical technique
of autometallographic silver amplification (AMG) found
heavy metals in spinal motor neurons in patients with
MND and controls, but the LC was not examined in that
study [3]. We therefore used AMG to examine heavy
metals in both LC and spinal motor neurons, using tis-
sue from previously-reported as well as from additional
MND patients in whom paraffin blocks containing the
LC were available. Updated histological criteria for heavy
metal staining and new quantitative procedures for the
presence of heavy metals in neurons were employed.
The CNS was also sampled widely to see if heavy metal
staining was specific for LC and motor neurons.Med Central Ltd. This is an Open Access article distributed under the terms of
tp://creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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Nomenclature
(1) The term “toxicant” is used to describe a poison that is
put into the environment by human activity, in contrast to
a toxin, which is a poison produced naturally by an organ-
ism; the term toxicant does not necessarily imply damage
to cells, since the toxicant may be at too low a concentra-
tion to cause cell injury. (2) The term “heavy metal” in this
study refers to the two metals that can be stained using
the routine AMG process, inorganic mercury and bis-
muth. Although it seems most likely that the metal dem-
onstrated by AMG in this study is inorganic mercury
(since exposure to bismuth is uncommon), we use the
term metal toxicant or heavy metal instead of inorganic
mercury since we cannot definitively identify the metal
concerned using paraffin sections. (3) Unless otherwise
stated, the term “locus ceruleus” (LC) refers to the locus
ceruleus nucleus in the pons, to prevent confusion with
the nucleus of an individual LC neuron.
Cases and controls
Cases
Cases were 24 patients (13 male, 11 female, age range 38–
84 years, mean age 61 years SD 13 years) with a clinical
diagnosis of MND, made by a neurologist, where the diag-
nosis was confirmed pathologically on post mortem exam-
ination of brain and spinal cord tissue performed between
1988 and 1999 (Table 1). MND cases were restricted to
those in whom available formalin-fixed paraffin-embedded
blocks contained: (1) Neuromelanin-containing neurons
of the locus ceruleus in the rostral pons. (2) Anterior horn
motor neuron cell bodies in the spinal cord (lumbar and/
or cervical). (3) Hypoglossal motor neurons in the medulla
oblongata. In MND patients tissue blocks were also
available from the frontal motor cortex, which had been
sampled horizontally to include the maximum number
of corticomotor neurons [4]), occipital cortex, midbrain,
hippocampus, caudate-putamen, and cerebellum.
The results of neurological examinations were incom-
plete in some of the archival cases, though family histor-
ies of MND were available from all. During this period
of tissue collection the only genetic tests available were
for mutations in the gene for superoxide-dismutase 1
(SOD1) and for repeat expansions in the androgen re-
ceptor gene for Kennedy’s disease, and no frozen tissue
was available for DNA extraction. We therefore immuno-
stained spinal cord sections with TDP-43 and CD-68, and
hippocampal and cerebellar sections with p62 and TDP-
43 to enable classification as: (1) Sporadic or familial
MND (FMND), based on family history. (2) Classic ALS,
based on upper and lower motor neuron loss, TDP-43 in-
clusions in spinal motor neurons, and increased microglia
in the lateral corticospinal tracts on CD-68 staining. (3)
Sporadic progressive muscular atrophy (SPMA) variant ofMND, based on lower motor neuron loss, TDP-43 inclu-
sions in remaining spinal motor neurons, and no increase
in microglia in the lateral corticospinal tracts on CD-68
staining [5]. Familial MND was further classified into
those with: (1) Mutations in SOD1 or the androgen recep-
tor gene. (2) Probable C9orf72 mutations, based on the
characteristic p62 neuronal inclusions in the hippocampus
or cerebellum [6]. (3) Unknown mutations, for patients
who did not fit into the previous two categories.
Controls
Controls were 24 individuals (12 male, 12 female, age range
24-86 years, mean age 59 years SD 20 years) in whom par-
affin blocks containing the locus ceruleus were available,
from the same sources and the same time period as the
MND blocks (Table 1). Controls consisted of: (1) Seventeen
individuals who died from non-neurological conditions
where no brain pathology was found. (2) Three individuals
who met the DSMIV criteria for alcohol abuse, but who
had no brain pathology. (3) Three individuals with Parkin-
son’s disease. (4) One individual with multiple sclerosis. In
addition to the control LC blocks, 6 controls had midbrain
blocks containing the substantia nigra, 6 had spinal cord
blocks, and 4 had medulla oblongata blocks.
The project was approved by the Human Ethics Com-
mittee of Sydney South West Area Health Service.
Autometallography
7 μm paraffin sections were stained for metal toxicants
using silver nitrate autometallography (AMG), a silver amp-
lification method which under routine conditions stains the
sulphides or selenides of mercury, silver, and bismuth [7,8].
Briefly, paraffin sections were placed in physical developer
containing 50% gum arabic, citrate buffer, hydroquinone
and silver nitrate at 26°C for 80 min in the dark, then
washed in 5% sodium thiosulphate to remove unbound sil-
ver. Sections were counterstained with Harris hematoxylin
and viewed under bright-field illumination. Because Harris
haematoxylin contains a small amount of mercuric oxide,
sections were also counterstained with mercury-free Im-
proved Harris haematoxylin, but no difference in AMG
staining was seen. Silver-coated metal deposits were seen as
black-staining grains. In each staining run, a positive
control section was included of mouse spinal cord
motor neurons which contained mercury deposits after
an intraperitoneal injection of 2 μg/g mercuric chloride
[9]. Parallel sections of selected AMG-staining sections
were pretreated for 2 h with 1% potassium cyanide to
distinguish any silver deposits, which disappear after
this treatment [10].
AMG staining of individual neurons was graded as:
(1) Negative, when there were no or fewer than 10
AMG grains per neuron. (2) Light, when there were 10
or more AMG grains restricted to pigment-containing
Table 1 Details of heavy metal staining in LC and motor neurons of MND patients and controls
















MND SALS 71 Female 0 68 0 Low - - - 4n-
SALS 62 Female 1 72 1 Low - - - 4n+
SALS 66 Female 2 90 2 Low + + - 4n-
SALS 38 Male 4 81 5 High - - - NA
SALS 77 Female 4 72 5 High + - - 4n+
SALS 81 Female 5 52 9 High ++ ++ ++ 3n+
SALS 59 Female 14 82 15 High - - - 4n-
SALS 46 Male 12 60 17 High ++ + + 4n+
SALS 67 Female 17 66 20 High ++ ++ ++ 4n-
SALS 45 Male 13 46 22 High - - ++ 4n-
SALS C9orf72 74 Male 15 48 24 High - - - 4n-
SALS 60 Female 32 79 29 High + + - 3n-
SALS 49 Male 27 57 32 High + + ++ NA
SPMA C9orf72 60 Female 0 60 0 Low + + - 4n-
SPMA 58 Male 11 97 10 High ++ - - 4n+
SPMA 84 Male 21 64 25 High + - - 3n-
SPMA 74 Male 23 48 32 High ++ - + 4n+
SPMA 53 Male 56 14 80 High + + - 4n-
FMND 70 Male 21 75 22 High - - - 4n-
FMND C9orf72 59 Male 2 32 6 High + - + 4n-
FMND C9orf72 76 Female 5 79 6 High + + - 4n-
FMND SOD1 41 Male 0 50 0 Low ++ - - 4n-
FMND SOD1 47 Female 4 90 4 High ++ + ++ 4n-
FMND Kennedy 53 Male 2 101 2 Low - - - 4n-
Control Normal 86 Female 0 35 0 Low + + + NA
Normal 55 Female 0 38 0 Low - - - NA
Normal 77 Male 0 42 0 Low - NA NA NA
Normal 24 Male 0 122 0 Low - NA NA NA
Normal 82 Female 0 66 0 Low NA NA NA NA
Normal 77 Female 0 29 0 Low NA NA NA NA
Normal 44 Male 0 90 0 Low NA NA NA NA
Normal 30 Female 0 82 0 Low NA NA NA NA
Normal 75 Female 0 45 0 Low NA NA NA NA
Normal 71 Male 1 74 1 Low NA NA NA NA
Normal 47 Female 1 57 2 Low NA NA NA NA
Normal 77 Female 2 98 2 Low NA NA NA NA
Normal 55 Male 3 99 3 Low NA NA NA NA
Normal 26 Male 3 54 5 High + + - NA
Normal 52 Female 6 75 7 High NA NA NA NA
Normal 54 Male 12 65 16 High NA NA NA NA
Normal 74 Male 9 35 20 High - - - 4n+
Alcohol 36 Male 0 58 0 Low NA NA NA NA
Alcohol 49 Female 0 70 0 Low NA NA NA NA
Pamphlett and Kum Jew Acta Neuropathologica Communications 2013, 1:81 Page 3 of 15
http://www.actaneurocomms.org/content/1/1/81
Table 1 Details of heavy metal staining in LC and motor neurons of MND patients and controls (Continued)
Alcohol 33 Male 20 57 26 High NA NA NA NA
Multiple sclerosis 51 Female 17 69 20 High NA NA NA NA
Parkinson dis. 83 Male 0 13 0 Low + NA NA 3n++
Parkinson dis. 72 Female 0 12 0 Low NA NA NA 4n+
Parkinson dis. 74 Male 0 11 0 Low NA NA NA 4n-
3n: Oculomotor neurons, 4n: Trochlear neurons, 12n: Hypoglossal neurons, NA: Not available, NAm: Nucleus ambiguus neurons, SMN: Spinal motor neurons
(see text for other abbreviations).
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(3) Dense, when there were more than 10 AMG grains in
non-pigmented regions of the neuron, or when the grains
were too compact to judge whether any underlying neur-
onal pigment was present.
Quantitation of locus ceruleus neurons containing AMG
grains
To compare the percentage of AMG-stained LC neurons
between MND patients and controls, a 10×10 grid, with
right and lower exclusion margins, viewed at 400× mag-
nification, was stepped sequentially through the LC. To
be included for quantitation, an AMG-stained LC neuron
was defined as any neuron (pigmented or non-pigmented)
with a maximum diameter greater than 26 μm (the length
of the side of one grid square) that contained 10 or more
AMG grains. Neurons counted were those enclosed by
an area bordered by the LC pigmented neurons. Large
(greater than 26 μm in diameter) non-pigmented neu-
rons made up about one-quarter of the neuronal count.
The numbers of neurons counted varies between cases
mostly because the area of the LC varies greatly through-
out its length. A pilot study indicated that the percentage
of AMG-stained LC neurons was similar between sides,
so only one randomly-selected side was counted. The
quantifier (RP) was blinded to the diagnosis by having the
label on each slide obscured. One slide counted on 10 dif-
ferent occasions gave a coefficient of error of less than 5%.
The small number of spinal motor neurons in SMND
patients did not allow for formal quantitation of AMG
staining.
Statistics
GraphPad Prism 5 was used to analyse contingency ta-
bles with Fisher’s exact test. Non-Gaussian continuous
variable results were analysed with Mann-Whitney non-
parametric tests. Double-sided p values were calculated
with alpha <0.05.
Results
Heavy metal staining in the brain and brain stem
The only CNS cells to stain for heavy metals were neu-
rons in the LC and motor neurons in the spinal cord
and brain stem. Heavy metal staining was not removedby potassium cyanide pre-treatment, indicating the
staining was not due to silver deposits [10]. This indi-
cates that the standard AMG method used in this study
demonstrated either mercury or bismuth in the cells
[11,12]. A summary of heavy metal staining in each indi-
vidual is shown in Table 1.
Heavy metals in the locus ceruleus
The density of neurons in cross-sections of the LC of
MND patients appeared similar to those of the normal
controls, as far as could be judged visually on one (vari-
able) level of the LC without formal quantitation. In the
three Parkinson’s disease patients, however, LC neuronal
density was reduced by about 80% when compared to
normal control counts at the same horizontal level of
the pons, leaving only a few scattered surviving neurons.
Heavy metals in LC neurons
Either no, light, or dense heavy metal staining could be seen
in LC neurons (Figure 1). A mosaic of LC neurons contain-
ing no, light or dense heavy metal staining was usually seen.
LC neurons with heavy metals mostly contained neurome-
lanin granules as well. In some neurons dense heavy metal
staining made it difficult to judge whether or not the
neuron contained any neuromelanin (Figure 1). No glial
cells within the LC contained heavy metals.
Comparison between heavy metal staining in MND and
control LC neurons
Significantly more MND patients (88%) than controls
(42%) had an LC that contained at least one neuron with
heavy metal staining (chi square p = 0.002) (Figure 2A).
In addition, MND patients had significantly greater per-
centages of LC neurons with heavy metals than controls
(MND median 9.5%, control median 0.0%, Mann–Whitney
p = 0.0006) (Figure 2B).
In both MND patients and controls, some LC contained
very few heavy metal-stained neurons, which are likely to
be insufficient in number to be of biological importance.
Percentages of LC neurons containing heavy metals were
therefore divided into upper and lower halves, based on a
median value for the whole cohort of 4% stained neurons
per individual. The low-percentage of AMG-stained neu-
rons (low%AMG) category had 0% to 3% heavy metal-
Figure 1 Heavy metal staining in the LC of a MND patient. (A) One LC neuron in this field stains densely with AMG, making it difficult to
judge whether the neuromelanin is obscured or whether this is a non-pigmented neuron. (B) A pigmented neuron with light AMG staining,
seen as more than 10 small black grains within the yellow-brown neuromelanin. (C) Three pigmented neurons with no quantifiable AMG grains
(none in the two neurons on the right, and fewer than 10 grains in the neuron on the left). (D) A large non-pigmented neuron with no heavy
metal staining. (E) Three small non-pigmented neurons with no heavy metal staining. No glial cells in the LC stain for heavy metals. Bar = 15 μm.
AMG and hematoxylin.
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percentage (high%AMG) category 4% or more heavy
metal-stained LC neurons per individual. The LC of
MND patients were significantly more likely to be in
the high%AMG category (75%) than those of controls
(25%) (chi-square p = 0.0012) (Figure 2C).
Comparison of heavy metal-stained LC neurons in
MND subtypes
The percentage of heavy metal-stained LC neurons per
individual varied widely in all three MND subgroups, inparticular in the sporadic progressive muscular atrophy
(SPMA) subgroup (Figure 3A). Low%AMG and high%AMG
categories were seen in similar numbers in all three sub-
groups (Figure 3B).
All except 1 of the 13 SALS patients had LC nuclei in the
high%AMG category. The MND patient with the highest per-
centage of heavy metal-stained LC neurons (80%) had
SPMA.
Five of the 6 familial MND (FMND) patients had
heavy metal-stained LC neurons, with 4 of these in the
high%AMG category.
Figure 2 Comparison of LC heavy metal staining between MND
patients and controls. (A) The number of MND patients having any
heavy metal staining neurons in their LC was greater than in controls
(chi square p = 0.002). (B) LC neurons containing heavy metal staining
were present in both MND and control groups, but were significantly
higher in the MND group (Mann–Whitney p = 0.0006). Bars =median
values. (C) When the percentages of LC neurons containing heavy
metals were divided into high (upper 50% of range) and low (lower
50% of range) categories, MND patients were predominantly in the
high category, significantly different to the mirror-image result in
controls (chi-square p = 0.0012).
Pamphlett and Kum Jew Acta Neuropathologica Communications 2013, 1:81 Page 6 of 15
http://www.actaneurocomms.org/content/1/1/81Heavy metals in LC neurons: the effects of age and gender
To look for age effects on heavy metal staining in the
LC, the cohort was divided into younger (24–59 years)
and older (60–86 years) groups, based on a median age
of 59.5 years. The group in the lower half of the age
range had a slightly greater proportion of LC nuclei in
the high%AMG category (58%) compared to the older
group (42%), but this did not reach statistical signifi-
cance (chi-square p = 0.39). Heavy metals did not there-
fore appear to accumulate in the LC with age. The
youngest individual to have AMG-stained LC neurons
was a 26 year-old normal control individual, and the old-
est an 84 year-old MND patient.
More males (61%) had LC in the high%AMG category
than females (39%), but this did not reach statistical sig-
nificance (chi-square p = 0.25).
Heavy metals in the LC in sporadic and familial MND
Four out of 6 (67%) FMND patients, compared to 15 out of
18 (83%) sporadic MND patients, had LC in the high%AMG
category. Therefore the majority of patients in both familial
and sporadic MND groups had heavy metals in the LC in
the high%AMG category (chi-square analysis not performed
due to small numbers in the FMND group). No uniformity
of LC AMG staining was present in SOD1 mutant or
C9orf72 mutant MND patient groups, with both high%AMG
and low%AMG categories within these groups.
Heavy metals in motor neurons
Spinal motor neurons
All MND patients had severe losses of anterior horn spinal
motor neurons, with fewer than 10 surviving neurons in
some patients. No formal quantitation of heavy metal-
stained spinal motor neurons could therefore be under-
taken. Sixteen (67%) of the 24 MND patients had heavy
metals in their spinal motor neurons; in 9 of these metal
staining was light (Figure 4A), and in 7 dense (Figure 4B,
C). Dense AMG staining was seen particularly in smaller
neurons, with adjacent normal-sized neurons often showing
no or only light AMG staining (Figure 4D).
Heavy metals were seen in spinal motor neurons of
all MND subgroups (SALS, SPMA and FMND). Three
Figure 3 Comparison of LC heavy metal staining in SALS, SPMA
and FMND patients. (A) The percentage of LC neurons containing
heavy metals varied widely in all MND subgroups, particularly in the
SMND group, but was not significantly different between groups.
Bars = median values. (B) All MND subgroups had more high (upper
50% of range) than low (lower 50% of range) category LC neurons
containing heavy metals, with no significant differences
between groups.
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motor neurons.
Heavy metals in both LC and spinal motor neurons
Heavy metals were present in both LC and spinal motor
neurons in 14 (58%) of the 24 MND patients. The ma-
jority of MND patients with LC AMG staining there-
fore also had spinal motor neuron AMG staining. Only
1 (17%) of the 6 control patients had both LC and
spinal motor AMG staining.Heavy metals in hypoglossal motor neurons
All 12 individuals with hypoglossal motor neuron AMG
staining (10 out of 24 MND patients, 2 out of 4 controls)
also had AMG-stained spinal motor neurons (Figure 5A).
On the other hand, 6 individuals who had AMG-stained
spinal motor neurons had no hypoglossal motor neuron
staining. Spinal motor neurons therefore appeared to take
up metal toxicants more avidly than hypoglossal motor
neurons.
Heavy metals in nucleus ambiguus motor neurons
Nucleus ambiguus neurons stained positively for heavy
metals in 8 out of 22 SMND patients where the nucleus
could be identified, and in 1 out of 4 controls (Figure 5B).
Heavy metal staining in the nucleus ambiguus followed
that in spinal motor neurons, apart from one SALS pa-
tient who had positive nucleus ambiguus staining but
negative staining in LC, spinal motor and hypoglossal
motor neurons.
Heavy metals in extraocular muscle motor neurons
Heavy metal staining in extraocular motor neurons, ei-
ther trochlear or oculomotor, was present in 6 (27%) of
22 MND patients (Figure 5C), and in 3 of 4 controls (2
of these having Parkinson’s disease).
Heavy metals in cortical motor neurons
No remaining cortical motor neurons contained AMG
grains in any MND patient (Figure 5D). No glial AMG
staining was present in the vicinity of these neurons.
Heavy metals in other neurons
An occasional neuromelanin-containing neuron in the
medulla oblongata contained heavy metals, in individuals
in whom either AMG-stained LC or spinal motor neurons
were also present. No heavy metal staining (not even a
single grain) was seen in pigmented or non-pigmented
neurons of the substantia nigra (Figure 6A) in any individ-
ual, including the 3 patients with Parkinson’s disease. No
heavy metal staining was seen in any individual in neurons
of the occipital cortex, hippocampus (Figure 6B), caudate-
putamen, or cerebellum (Figure 6C). Neurons that con-
tained abundant lipofuscin, such as those in the cerebellar
dentate nucleus (Figure 6D) or the inferior olivary nucleus
(Figure 6E), also contained no heavy metals. No heavy
metals staining were seen in glial cells in any CNS region.
Discussion
This study suggests that human LC neurons contain heavy
metals quite commonly. These LC heavy metals are, how-
ever, more likely to be found in patients with MND than
controls. In the majority of MND patients, heavy metals
were detected in spinal motor neurons as well. The AMG
silver amplification technique used detects the sulphides
Figure 4 Heavy metal staining in spinal motor neurons of MND patients (B, C and D from the same patient in Figure 1). (A) Light AMG
staining can be seen within the lipofuscin of this normal-appearing spinal motor neuron, but none is present in the non-pigmented cytoplasm.
Bar = 7 μm. (B) and (C) Two shrunken spinal motor neurons with dense AMG staining, which is either obscuring the lipofuscin, or is free in
the cytoplasm. Bars = 20 μm. (D) A shrunken spinal motor neuron contains dense heavy metal staining (closed arrow), whereas an adjacent
normal-sized neuron (open arrow) contains no heavy metal staining, despite containing lipofuscin. Bar = 15 μm. AMG and hematoxylin.
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was removed chemically from the tissues, AMG staining
was still present, indicating that either mercury and bis-
muth was likely to be causing the staining. Human expos-
ure to bismuth is rare, occurring mostly after consumption
of bismuth-containing medications [12]. Therefore the
metal seen on AMG in this study is most likely to be mer-
cury, a known neurotoxicant with numerous natural and
anthropogenic sources [13].The locus ceruleus is a potential pathway for toxicants to
enter the brain
Experimental animal studies show that circulating metal
toxicants enter motor neurons selectively, probably via
retrograde axonal transport from the neuromuscular
junction [14]. However, only recently has it been shown
that a heavy metal, inorganic mercury, enters LC neu-
rons selectively as well [2]. This entry into the LC prob-
ably occurs because the LC innervates the great bulk of
Figure 5 Heavy metal staining in MND brain stem and cortical motor neurons. (A) Light AMG staining is present within the lipofuscin of
three hypoglossal motor neurons. Bar = 15 μm. (B) These two nucleus ambiguus neurons contain light AMG staining. Bar = 20 μm. (C) Light AMG
staining is seen within the lipofuscin of a trochlear nucleus neuron. Bar = 25 μm. (D) A shrunken cortical motor neuron (Betz cell, arrow) contains
no AMG grains. Bar = 15 μm. AMG and hematoxylin.
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lume of circulating blood. In fact, a rough calculation indi-
cates that, with the number of normal human LC neurons
being 32,000 [16] and the total capillary length of the brain
being 640 kilometres [17], each LC neuron on averageinnervates a 20 meter length of capillary [18]. The LC con-
tains numerous neurotransmitters in addition to noradren-
aline [19], and re-uptake of these neurotransmitters at
capillary terminals could be harnessed by a number of toxi-
cants to enter the LC via recycling mimicry [20].
Figure 6 Negative heavy metal staining in different CNS regions (all from the same MND patient in Figure 1 and Figure 5B, C and D).
No heavy metal staining was present in: (A) Neuromelanin-containing neurons of the substantia nigra. Bar = 25 μm. (B) Neurons in the dentate
gyrus of the hippocampus. Bar = 50 μm. (C) Purkinje cells (arrow) in the cerebellar cortex. Bar = 20 μm. (D) Lipofuscin-containing neurons in the
cerebellar dentate nucleus. Bar = 25 μm. and (E) Lipofuscin-containing neurons in the inferior olivary nucleus. Bar = 30 μm. AMG and hematoxylin.
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In our previous study, we found no heavy metals in in-
fant motor neurons, and suggested that metals were
likely to accumulate in motor neurons during aging [3].
In the present study, there was no correlation between
increasing age and heavy metal content of the LC. This
raises the possibility that toxicant exposure in these individ-
uals was episodic, rather than continuous, in nature. Expos-
ure may occur early in life, as evidenced by one 26 year-old
man without neurological disease already having heavymetals within his LC. One possible reason for this early
LC uptake of toxicant is that stressor-induced upregula-
tion of the LC promotes bursts of toxicant intake into the
nucleus [2].
The amount of intracellular heavy metal varies widely
between adjacent locus ceruleus neurons
A question that cannot be answered by this study was why
only some LC neurons contained heavy metal staining,
with densely-stained neurons usually found adjacent
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also seen in a man who injected himself with a large dose
of metallic mercury [2]. Topographic outputs of the ro-
dent and primate LC to various brain regions have been
described, but not at the level of individual LC neurons.
Possibilities are that the toxicant-containing LC neurons
have a particularly large output to the capillary bed and so
are exposed to greater amounts of circulating toxicant.
Another possibility is that specific stressors, e.g., those re-
quiring the LC to activate the motor system, result in the
uptake of toxicants into LC neurons that are activated to
deal with those specific stressors.
Could toxicants in the locus ceruleus trigger MND?
We were not able to detect heavy metals in cortical
motor neurons, despite these neurons being affected in
ALS, and being shown to contain mercury after expos-
ure to metallic mercury [2]. This could be because of a
survivor effect, with the toxicant-containing cortical
motor neurons dying early and leaving only toxicant-free
motor neurons intact. Secondly, toxicants within the LC
may reduce noradrenaline output to the cortical motor
neurons and secondarily damage cortical motor neurons,Figure 7 Potential interactions between toxicant-containing LC and m
could reduce noradrenaline output, resulting in: (A) A dysfunctional blood-
toxicants, or to inflammatory agents. (B) Decreased astrocytic function lead
the neuron. (D) Microglial activation and inflammation. (E) Oligodendrocytwithout the need for a toxicant to be within cortical
motor neurons. After being activated by a stressor, LC
neurons supply noradrenaline directly to motor neurons,
as well as to microvessels and glial cells, all of which
have noradrenaline surface receptors (Figure 7).
Recent studies indicate that many CNS cells have nor-
adrenaline receptors, so reduced noradrenaline output
can cause a number of deleterious changes to neurons
[19,21]. These include changes that are implicated in
MND, such as blood–brain barrier permeability to toxi-
cants or inflammatory agents [22], decreased astrocytic
function leading to increased synaptic glutamate [23], re-
duced trophic support to the neuron [24], microglial ac-
tivation and inflammation [25], and oligodendrocyte
dysfunction causing impaired myelination [26]. Finally, it
has been suggested that the LC could transfer toxicants
from the circulation to cortical motor neurons [2], since
the LC makes direct contact with both capillaries and
motor neurons. A further discussion on how toxic dam-
age to the LC could result in different neurological con-
ditions has recently been published [18].
No technique currently exists to reliably measure the
concentration of toxicants such as heavy metals withinotor neurons (see text for details). Toxicant uptake into the LC
brain barrier, which becomes permeable to the same or other
ing to increased synaptic glutamate. (C) Reduced trophic support to
e dysfunction causing impaired myelination.
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sess how much heavy metal is in LC neurons. The lack of
obvious neuronal loss in the metal-containing LCs of our
MND patients could lead to the presumption that the
amount of heavy metal was insufficient to damage the neu-
rons. However, it has previously been shown that mouse
spinal motor neurons that contain a non-toxic dose of inor-
ganic mercury suffer axonal shrinkage, without any loss of
numbers of motor neuron cell bodies [9]. This indicates
that a low dose of a heavy metal can cause neuronal dam-
age without cell body loss, and by extrapolation suggests a
loss of noradrenaline from LC terminals could occur with-
out the loss of toxicant-containing LC cell bodies. Of inter-
est, one of the few quantitative studies of the LC in MND
has shown neuronal shrinkage of LC cell bodies without
cell loss [27], though no unbiased quantitative studies of
cell numbers in the LC of MND patients have been re-
ported. Even a moderate level of LC neuronal damage
could have a deleterious effect on spinal motor neurons,
since the long LC axons extending down to the spinal cord
would be particularly susceptible to toxic disturbances in
their parent cell bodies [28].
AMG can detect only a few heavy metals, but environ-
mental exposures usually involve different types of toxi-
cants, often simultaneously. For example, cigarette smoke,
a possible risk factor for MND [29], contains 4,800 identi-
fied compounds, including metal toxicants [30]. The heavy
metals identified in this study may not therefore be a
cause of neurotoxicity, but may merely be a marker that
indicates how readily a number of toxicants are entering
LC and motor neurons.
Although we have suggested here that heavy metals in
the LC could play a part in the pathogenesis of MND,
an alternative explanation for the presence of heavy
metals in the LC is that metals enter the LC after the
start of the disease. Stress-induced uptake of toxicants
could take place after the onset of MND, because having
a disease such as MND is likely to be highly stressful.
The finding of heavy metals in the LC could therefore
be a result of having the disease, rather than being a
trigger for the disease.
Heavy metal staining in extraocular muscle neurons
Extraocular muscles are affected late or not at all in MND
[31]. Extraocular muscle neurons contained the least
heavy metal staining of all the motor neurons in the
present study, raising the possibility that one reason they
are spared is because they take up smaller toxicant loads.
This may be because their neuromuscular junctions are
different to those of other muscles [32]. Curiously, 2 out
of 3 Parkinson’s disease patients had heavy metals in their
extraocular muscle neurons; whether this is related to the
oculomotor problems associated with Parkinson’s disease
[33] would require further study.Phenotypic variation in familial and sporadic MND: do
toxicants play a part?
Heavy metal-containing neurons were found in this
study in familial, and not only sporadic, MND. One pos-
sibility for this is that FMND-associated mutations in-
crease the neuronal uptake of toxicants, possibly by
altering the permeability of the blood–brain barrier as
has been suggested for SOD1 [34], TARDBP and ANG
mutations [35]. Other FMND mutations could damage
mechanisms that protect neurons from toxicants, as has
been suggested for a number of MND genetic variants
[36].
The presence of toxicants within LC and motor neu-
rons could also explain the intra-familial variations in
age of disease onset and phenotype that is seen in
FMND, as well as the inter-patient variations commonly
found in sporadic MND. For example, we found that the
heavy metal content varied between hypoglossal and
spinal motor neurons, a possible reason why bulbar
symptoms can appear early, late or not at all in MND.
Heavy metal staining in non-MND disease controls
With the recent finding of LC damage in multiple scler-
osis [37] it is of interest that the LC of one multiple
sclerosis patient contained heavy metals. The heavy
metal staining within the LC of one individual with alco-
holism accords with the finding by some workers that
LC neurons are damaged by alcohol excess [38].
Identification and quantification of heavy metals in neurons
Ideally, AMG should be followed up with some elemental
method to confirm the identity of the heavy metal in the
tissue. This has been achievable in humans exposed to
large amounts mercury or bismuth, where enough of the
metal was present in the tissues for quantitative methods
to be of use [12]. However, AMG, being an amplification
technique, is more sensitive to the presence of toxicant
metals than other currently available techniques of metal
detection (such as neutron activation analysis, proton-
induced X-ray emission, atomic absorption spectropho-
tometry, and electron emission X-ray spectrophotometry),
though the lower amount of heavy metal that can be de-
tected with AMG has not been ascertained [10]. Unfortu-
nately, microprobe elemental analyses performed on
formalin-fixed paraffin sections are considered to be unre-
liable [39]. In our study, only a small proportion of the
total number of cells in the pons, brain stem and spinal
cord had AMG staining, which suggests only an in situ
microprobe technique, carried out on frozen sections,
would have a chance of detecting toxicants in the LC.
Motor neuron loss in most MND cases was too severe to
be able to identify toxicants using elemental analysis.
AMG has been used extensively to study the distribu-
tion of metal toxicants in experimental animals, used
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[2,12,40], but used only rarely in humans with no known
toxicant exposure [11]. Humans differ from most non-
primate animals in having extensive neuromelanin pigmen-
tation in catecholaminergic neurons, as well as having
lipofuscin in many aging neurons, including motor neu-
rons [41]. It is therefore important to ensure that the
AMG staining seen in human neurons is related to heavy
metal staining, and not to some unknown reaction within
pigmented neurons. The fact that no heavy metal staining
was seen in any neuromelanin-containing neurons of the
substantia nigra, or in other neurons containing high
levels of lipofuscin, indicates that these pigments them-
selves are unlikely to be the source of the AMG staining.
The heavy metals in this study localised preferentially
to the neuromelanin of LC neurons, and to the lipofus-
cin of motor neurons, probably because these pigments
can bind metals [41]. Neuromelanin in the substantia
nigra of neurologically-normal individuals has an affin-
ity for a number of physiologic and exogenous metal
ions, including mercury [42]. It has been suggested that
the neuromelanin of the substantia nigra could play dif-
ferent roles in Parkinson’s disease, firstly as a protect-
ant by scavenging toxic substances such as exogenous
metals and pesticides, and later as a destructive agent
when cell death releases the neuromelanin [43]. Neuro-
melanin granules are probably not membrane-bound,
and toxicants in unbound neuromelanin would be free
to interact with cellular constituents [41].
Quantitation of the metal content of neuromelanin
isolated from the substantia nigra of neurologically-
normal individuals shows how neuromelanin can se-
quester toxic metals that arise from environmental
exposure, with many-fold accumulations of mercury
(1:96) and lead (1:1408) compared to surrounding tis-
sue (no corresponding data are available for LC neuro-
melanin) [44]. Of note, however, was the absence of
stainable heavy metals in any substantia nigra neurons
in our study, despite the probability of age-related
heavy metal sequestration by neuromelanin in these
neurons. This suggests that the AMG staining we did
see in the LC, especially in densely-stained neurons,
represents a concentration of heavy metal that could
be physiologically active. Indirect evidence of the po-
tential toxicity of the level of AMG staining seen is also
given by the findings from a man who injected himself
with a large amount of metallic mercury [2], after
which similar AMG staining of many LC neurons was
seen, comparable in particular to the densely-stained
neurons in the present study.
Study limitations
Our study has a number of limitations: (1) The number
of controls who had both LC and spinal cord tissueavailable was limited, since spinal cord tissue was usu-
ally removed at post mortem from controls only when
clinically indicated, and LC-containing blocks were not
available from all potential controls. (2) Only one (vari-
able) level of the LC was available for examination, so
we were unable to determine if differences in heavy
metal content were present in rostral, middle and caudal
parts of the LC; of note, cell loss in the LC in Alzheimer's
and Parkinson's diseases has been found to vary along the
length of the LC [45]. (3) We could not reliably detect
the subceruleus, which in primates is thought to inner-
vate spinal motor neurons [46]. (4) No histories of toxi-
cant exposure were available, so we do not know if any
individuals had exposure to higher than normal levels of
mercury (e.g., living near an incinerator or a coal-burning
power station) or had been taking bismuth-containing
medications. (5) No psychological, psychiatric, or stressful
life events histories were available, so we were unable to
determine levels of stress before the onset of MND. This
is of potential importance, since it has been suggested that
stress, by activating the LC, could increase the uptake of
toxicants into LC neurons [2]. (6) As noted above, we
were unable to identify the type of heavy metal using par-
affin sections, though this is likely to be inorganic mercury
since human exposure to bismuth is limited.
Future studies
The finding of potential disease-causing toxicants in a
CNS region that is not morphologically damaged by
MND has implications for further neurotoxicological in-
vestigations into this disease. Attempts to locate toxicants
in MND tissues have generally been unsuccessful, prob-
ably because toxicant-containing motor neurons have
largely disappeared by the time of death, and bulk ana-
lysis of tissue is unlikely to detect toxicants affecting a
small percentage of cells. An intact LC, however, is com-
pact and easily located, and would be an ideal candi-
date region for newer microanalysis methods that can
detect a range of toxicants [47].
The heavy metals within LC neurons in the present
study did not appear to cause structural damage to the
neurons, and only minor changes in LC neuronal size
have been reported in MND [27,48]. There are however
a number of neurodegenerative and psychiatric disorders
where structural damage to the LC with associated nor-
adrenaline deficits have been described. Chief among
these are Parkinson’s disease, Alzheimer’s disease, major
depression and bipolar disorder [18,49,50]. In Alzheimer's
disease it has been suggested that the LC is the first region
of the brain to be involved by the disease, and at a very
early age [51]. Environmental toxicants have been associ-
ated with all these disorders, and a search for toxicants
within the LC of these patients could yield interesting
results.
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In conclusion, we have shown that the uptake of heavy
metals by the human LC is a fairly common occurrence,
and is seen more in MND patients than controls. The
combination of toxicant uptake by the LC and lower
motor neurons could result in damage to cortical and
lower motor neurons. Toxicant-induced LC damage with
subsequent decreases of noradrenaline may explain the
involvement in MND of multiple CNS regions and cell
types. Further studies using newer methods of elemental
analysis should be able to inform us as to whether a
range of toxicants resides in the LC of MND patients, as
well as in other diseases where the LC is damaged.
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